Bobby Gaspar - 01 Jun 2022 Form 4 Insider Report for Orchard Therapeutics plc

Role
Chief Executive Officer, Director
Signature
/s/ Bobby Gaspar
Issuer symbol
N/A
Transactions as of
01 Jun 2022
Net transactions value
$0
Form type
4
Filing time
03 Jun 2022, 08:00:12 UTC
Previous filing
05 Apr 2022
Next filing
06 Oct 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ORTX Stock Option (Right to Buy) Award $0 +422,631 $0.000000 422,631 01 Jun 2022 Ordinary Shares 422,631 $0.4591 Direct F1, F2
transaction ORTX Stock Option (Right to Buy) Award $0 +427,369 $0.000000 427,369 01 Jun 2022 Ordinary Shares 427,369 $0.5739 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to this option shall vest and become exercisable in forty-eight (48) equal monthly installments, with the first installment vested on March 1, 2022.
F2 The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.